Nosocomial infection is a major problem in the world today. Methicillin-resistant Staphylococcus aureus (MRSA) strains, usually resistant to several antibiotics, shows a particular ability to spread in hospitals and is now present in most of the countries.
IntroductIon
Five to ten percent of hospitalized patients develop nosocomial infections. 1 The larger the referral hospital, the higher is the rate of these infections. 2 Methicillinresistant Staphylococcus aureus (MRSA) frequently causes nosocomial infections, is often resistant to most of the antibiotics and is one of the greatest challenges for modern antimicrobial therapy, particularly since the emergence of Staphylococcus aureus (S. aureus) with intermediate susceptibility to glycopeptides. 3 Recent studies suggest that the infection due to MRSA is not only hospital-acquired but community acquired as well. 4 MRSA now represent a global problem. 5 Some large outbreaks have been reported from different parts of the world, where it had caused severe infections including septicemia, endocarditis and meningitis. 5 A study by Dickinson in England and Wales has concluded an increase in the trend of death due to MRSA infection. 6 Infections caused by MRSA can be expensive in terms of antibiotic therapy, isolation facilities and materials and length of hospital stay. According to a World Health Organization literature, the global financial burden because of MRSA infection has been worked out to be $20,000 to $ 114,000 for outbreaks and from $28,000 to $1600,000 for endemic infections per year. 5 The common sources of these infections are human patients and carriers. 7 The risk factors that contribute to MRSA are antibiotics abuse, prolonged hospitalization, intravascular instrumentation and hospitalization in an intensive care unit. 8 There is considerable variation in numbers of clinical infections among units, hospitals and countries.
MAterIAl And Methods
A total of 750 S. aureus strains were isolated during a period of one year from, June 2003 to June 2004. The organisms were obtained from various clinical samples like pus, sputum, genital specimens (high vaginal swab, semen, urethral discharge), urine, blood, body fluids (cerebrospinal fluid, ascitic fluid, plural fluid, synovial fluid etc.), devices (urinary catheter, endotracheal tube, CVP catheter, tracheostomy tube, PD catheter, drain, suction catheter) and tissues. Standard isolation procedures were applied to all the samples. Identification of S. aureus was confirmed by standard coagulase; susceptibility testing for oxacillin (1 µgm disc from Himedia Laboratories Pvt. Ltd. India) was also performed by Kirby-Bauer's disk diffusion on Mueller-Hinton agar with 24 hours incubation at 35 °C . Interpretation criteria were those of the national committee for clinical laboratory standards (NCCLS). 9 A zone of inhibition of less than 10 mm or any discernible growth within the zone of inhibition was taken as indicative of methicillinresistance (screening out MRSA strains). Methicillinresistance was confirmed by agar screen test using Mueller-Hinton agar plate supplemented with 4% NaCl and oxacillin (6µgm/ml). The antimicrobial susceptibility pattern of all the MRSA strains were determined against the following antibiotics: 
results
Out of the total of 750 strains of S. aureus, 196 were found to be MRSA (26.14%). The maximum isolation of MRSA was from pus and wound swabs. The number and percentage of isolation of MRSA from different clinical specimens (Table 1) . Seventy percent of the MRSA isolates was from the inpatient departments. The majority of the samples were obtained from Surgery (24%) and Orthopedics units (16%). MRSA observed in intensive care units (ICU) represented 10% of the cases (Figure 1 ). More than 65% of MRSA were found to be resistant to the majority of the antibiotics tested ( Figure  2 ). Many of the MRSA strains were resistant to all the antibiotics tested except Vancomycin.
dIscussIon
Scanty data regarding MRSA is available from Nepal, to the best of our knowledge. The prevalence rate of MRSA infection in our study was found to be 26.14%, which is in accordance with the reports by Udaya et al (20%) and Mehta et al (32.8%) from India. [10] [11] On the contrary, some of the reports show an alarmingly high incidence of MRSA infection. [12] [13] An important finding of the present study was that the MRSA cases from ICU accounted for only 10% of all cases. Our finding is in agreement with the findings of Dominique et al 3 from Switzerland. These findings illustrate the efficacy of relatively good infection control practice in our hospital.
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In the study, Penicillin-resistance was observed to be 100% against the organism. This corroborates with the finding of Anupurba et al. 12 The resistance for Ceftazidime and Cephotaxime were 72.45% and 62.24% respectively (β-lactam resistance). Resistance to quinolones like Ciprofloxacin and Ofloxacin were 67.35% and 62.24% respectively. This is probably due to the indiscriminate and empirical use of these drugs. Further, quinolones are relatively cheaper and easily available as over-the-counter drugs in Nepal. Findings of this resistance in our study is relatively less than those of Uday et al (95.8%) and Mehta et al (68%). [10] [11] Aminoglycosides also were found to be resistant. This is due to the fact that MRSA is often multidrugresistant.
Vancomycin seems to be the only antimicrobial agent which showed 100% sensitivity and so may be used as the drug of choice for treating multidrug-resistant MRSA infections. Vancomycin is not a commonlyprescribed drug, which is almost certainly due to the higher price of the antibiotic and its unavailability in many parts of the country.
conclusIon Therefore, regular surveillance of hospital-associated infections including monitoring of antimicrobial (especially Vancomycin and other newer glycopeptides) susceptibility pattern of MRSA and formulation of a definite antimicrobial policy may be helpful for reducing the incidence of these infections. Infected or colonized patients may be isolated in a single room or isolation unit to prevent the spread of MRSA. Knowledge about MRSA and carrier status needs to be raised among the health staff of the hospital and control measures need to be implemented consistently in order to reduce the burden of MRSA infection in the hospital environment. A further study of MRSA may be done for the epidemiological mapping of these infections. 
